The Indian healthcare sector is currently grappling with a significant **medical device cost surge**. This crisis stems from escalating geopolitical tensions in the Strait of Hormuz, which are rippling through the medical supply chain. Consequently, manufacturers are flagging a sharp rise in raw material prices and potential shortages of essential clinical items. Meanwhile, the Association of Indian Medical Device Industry (AiMeD) reports that input costs for plastics have jumped by nearly 50 percent. Furthermore, the price of gas used for process heating and power generation has doubled. These factors are severely eroding the thin margins on items like syringes and catheters. Manufacturers warn that while short-term delays are manageable through inventory buffers, prolonged disruptions could halt production entirely.

Economic Drivers Behind the Medical Device Cost Surge

Several domestic factors are exacerbating the current situation. Specifically, major suppliers like Reliance Industries Limited have implemented frequent price hikes for polymers such as polypropylene and polyethylene. Since early March, these essential materials have seen multiple upward revisions. Currently, the industry also faces structural financial strain from an inverted GST structure. Therefore, the industry has urged the government to expedite GST refunds to provide much-needed liquidity support.

Despite these pressures, some manufacturers are choosing to shield patients from immediate price hikes. For instance, companies like HMD are utilizing lower-cost existing inventory to cushion the impact for now. However, experts caution that this strategy is unsustainable if input costs remain elevated. Without timely intervention, these disruptions could jeopardize five lakh jobs. Additionally, they might affect affordability and dent India’s Atmanirbhar Bharat goals.

Frequently Asked Questions

Q1: Why are medical device prices rising in India?

The primary reason is the geopolitical tension in the Strait of Hormuz, which has led to a 50% increase in the cost of raw materials like plastics and a 100% surge in gas prices.

Q2: Which medical items are most affected by the current supply chain crisis?

Essential consumables such as syringes, catheters, IV sets, and blood bags are the most affected because they rely heavily on petrochemical-based polymers like polypropylene and PVC.

Q3: How is the industry body AiMeD responding to these cost pressures?

AiMeD has raised concerns over opportunistic price gouging and is urging the government to expedite GST refunds and provide liquidity support to prevent hospital shortages.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Hormuz Tensions Push Device Costs Up 50%, Shortage Fears Rise - ETHealthworld


2. Medical device makers face cost squeeze as gas curbs and polymer prices surge - Business Today (March 12, 2026)


3. West Asia war may trigger shortage of key hospital supplies - The Times of India (March 12, 2026)